Patent: 7,915,263
✉ Email this page to a colleague
Summary for Patent: 7,915,263
Title: | Aminopyridine derivatives having aurora A selective inhibitory action |
Abstract: | The present invention relates to a compound of formula I: ##STR00001## wherein: R.sub.1 is a hydrogen atom, F, CN, etc.; R.sub.1\' is a hydrogen atom or lower alkyl which may be substituted; R.sub.2 is O, S, SO, SO.sub.2, etc.; R.sub.3 is a phenyl which may be substituted; X.sub.1, X.sub.2, and X.sub.3 each independently CH, N, etc. provided, however, that among X.sub.1, X.sub.2 and X.sub.3, the number of nitrogen is 0 or 1; W is the following residue: ##STR00002## wherein: W.sub.1, W.sub.2, and W.sub.3 each independently CH, N, etc., or a pharmaceutically acceptable salt or ester thereof. |
Inventor(s): | Iwasawa; Yoshikazu (Tsukuba, JP), Kato; Tetsuya (Tsukuba, JP), Kawanishi; Nobuhiko (Moriya, JP), Masutani; Kouta (Tsukuba, JP), Mita; Takashi (Tsukuba, JP), Nonoshita; Katsumasa (Tsukuba, JP), Ohkubo; Mitsuru (Ushiku, JP) |
Assignee: | Banyu Pharmaceutical Co., Ltd. (Tokyo, JP) |
Application Number: | 11/897,272 |
Patent Claims: | see list of patent claims |
Details for Patent 7,915,263
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | THYROGEN | thyrotropin alfa | For Injection | 020898 | 11/30/1998 | ⤷ Try a Trial | 2026-08-31 |
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2026-08-31 |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2026-08-31 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2026-08-31 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2026-08-31 |
Eisai, Incorporated | ONTAK | denileukin diftitox | Injection | 103767 | 02/05/1999 | ⤷ Try a Trial | 2026-08-31 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2026-08-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |